Academic partner
of Lymphoma
Clinical Research


The main objectives of lymphoma clinical research are the development of better tolerated and more effective treatments and the optimization of therapeutic combinations and regimens for every subtype of lymphoma.

la-recherche-cliniqueMoreover, the search for new biomarkers for diagnostic, prognosis and theranostic use is nowadays an important objective ancillary to most of the clinical protocols, from collected, clinically documented tumor, blood, genetic and imaging materials.
Organizations which own these collections and corresponding data are in the most suitable position to perform retrospective analyzes, clinical-biological correlation research, subpopulation studies and meta-analyzes.
Finally, the regulatory requirements for pharmacovigilance and the need to evaluate therapy effects on the long run make more and more important a long-term follow-up of patient survival and possible late drug toxicities, even after the termination of clinical trials.